Analytical Performance and Clinical Utility of a Bioassay for Thyroid-Stimulating Immunoglobulins

DOI PDF 被引用文献1件
  • Johannes J. Leschik
    1Molecular Thyroid Research Laboratory, Department of Medicine I, Johannes Gutenberg University Medical Center, Mainz, Germany
  • Tanja Diana
    1Molecular Thyroid Research Laboratory, Department of Medicine I, Johannes Gutenberg University Medical Center, Mainz, Germany
  • Paul D. Olivo
    2Diagnostic Hybrids, a Quidel Company, Athens, OH
  • Jochem König
    3Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), Division Medical Biometry, Johannes Gutenberg University Medical Center, Mainz, Germany
  • Ulrike Krahn
    3Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), Division Medical Biometry, Johannes Gutenberg University Medical Center, Mainz, Germany
  • Yunsheng Li
    2Diagnostic Hybrids, a Quidel Company, Athens, OH
  • Michael Kanitz
    1Molecular Thyroid Research Laboratory, Department of Medicine I, Johannes Gutenberg University Medical Center, Mainz, Germany
  • George J. Kahaly
    1Molecular Thyroid Research Laboratory, Department of Medicine I, Johannes Gutenberg University Medical Center, Mainz, Germany

抄録

<jats:title>Abstract</jats:title> <jats:p>The analytical performance and the clinical utility of a thyrotropin receptor (TSHR)–stimulating immunoglobulin (TSI) bioassay were compared with those of a TSHR-binding inhibitory immunoglobulin (TBII) assay. Limits of detection (LoD) and quantitation (LoQ), assay cutoff, and the half-maximal effective concentration (EC50) were measured. Dilution analysis was performed in sera of hyperthyroid patients with Graves disease (GD) during antithyroid treatment (ATD). Titer was defined as the first dilution step at which measurement of TSI or TBII fell below the assay cutoff. The LoD, LoQ, cutoff, and EC50 of the bioassay were 251-, 298-, 814-, and 827-fold lower than for the TBII assay. There were 22%, 42%, 23%, and 14% more positive samples in the TSI bioassay at dilutions of 1:3, 1:9, 1:27, and 1:81 (P &lt; .0001), respectively. Responders to ATD demonstrated marked differences in titers compared with nonresponders. The bioassay detected lower levels of TSHR autoantibodies, and the dilution analysis provided similar predictive values of both assays in GD.</jats:p>

収録刊行物

被引用文献 (1)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ